• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Monday 12/10/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

diagnostics

  • 2:42 PM

    Cannabics patent granted with enabling technology to personalize Cannabinoid diagnostics and treatment for Cancer patients PR Newswire TEL AVIV, Israel and BETHESDA, Maryland, April 18, 2018 TEL AVIV, Israel and BETHESDA, Maryland, April 18, 2018 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in cannabinoid diagnostics for the personalized treatment of cancer, today announced the receipt of a Notice of Allowance from The Patent Office of the State of Israel. The Patent Office intends to grant Cannabics the patent for its method of high throughput screening of

    Read more
  • 9:44 AM

    CODX updates on initial six months as a public company SALT LAKE CITY–(BUSINESS WIRE)– Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced the filing of its initial Annual Report on Form 10-K as a public company. Co-Diagnostics completed its initial public offering (“IPO”) on July 17, 2017. 2017 Financial Results: Revenue for the year totaled $7,700, primarily licensing revenue, compared to zero revenue in full year 2016. Deferred income

    Read more
  • 10:58 AM

    Sales expected upon successful performance evaluation and validation SANDY, Utah–CODX, (BUSINESS WIRE)– Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that they have strengthened relationships with key regional customers throughout the Caribbean basin to purchase the Company’s Zika virus diagnostic. The potential customer base includes laboratories, regional health ministries, and hospitals interested in offering a state-of-the-art molecular diagnostic for the Zika virus to their

    Read more
  • 12:26 PM

    SALT LAKE CITY–CODX, (BUSINESS WIRE)– Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced today the recent incorporation of CoSara Diagnostics, Pvt., Ltd., a Joint Venture for manufacturing with Synbiotics Limited. Synbiotics is a group company of Asence Inc, a U.S. incorporated company specializing in supplying pharmaceutical products to international markets. Co-Diagnostics and Synbiotics incorporated the CoSara entity in India in July. Co-Diagnostics paid

    Read more
  • 2:04 PM

    Allowance Strengthens Commercialization Strategy of Company’s Proprietary Diagnostics and Therapeutics SALT LAKE CITY, UT, PRED,–(Marketwired – December 16, 2016) – Predictive Technology Group, Inc. (OTC PINK: PRED), a life sciences technology holding company, announced today that the United States Patent and Trademark Office (USPTO) has allowed a fundamental patent application — US20160296671 -that covers the practice of administering “ANY” spine deformation therapeutics to a patient having a spine deformation altered risk associated biomarker. “We are pleased to see this latest

    Read more
  • 3:27 PM

    DELRAY BEACH, Fla., Aug. 26, 2016, PSID, (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that it has completed its acquisition of Thermomedics Inc., the designer and marketer of the Caregiver® infrared, non-contact thermometer, which is FDA-cleared for clinical use. Under a management services and control agreement (the “Control Agreement”), PositiveID assumed full operational control of Thermomedics in December 2015. PositiveID has now completed the acquisition of the

    Read more
Public Wire Banner